Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

"Rapid development of a COVID-19 candidate vaccine"


Professor Adrian HillProfessor Adrian Hill is Director of the Jenner Institute at Oxford University. He trained in medicine at Trinity College, Dublin and Oxford.  His group has designed, manufactured and developed many new vaccines for malaria, exploring a range of vaccine technologies that have informed progress for vaccine design against many diseases. 

His current lead malaria vaccine has shown high efficacy in clinical trials in the UK and Africa and is likely to be the first widely used vaccine to impact on the great disease burden of malaria in Africa.

In 2005 he founded the Jenner Institute at Oxford, an initiative aimed at accelerating public sector vaccine development for a range of infectious diseases, and partnered with the Pirbright Institute on veterinary vaccine development. The Jenner Institute is now the largest academic vaccine centre globally with clinical-stage vaccine programmes against thirteen diseases. 

In 2014 he led the first clinical trial of an Ebola vaccine targeted at controlling the Ebola outbreak in West Africa, and Oxford assessed a further three candidate Ebola vaccines in the UK and Africa over the next year. This led to a major initiative at the Jenner Institute targeting vaccine development for a wide range of outbreak pathogens. Recently this programme has facilitated a major effort towards rapid development of a COVID-19 vaccine. A clinical trial of which he is the Oxford principal investigator has started recently.

He has published 600 research papers with over 68,000 citations and co-founded several vaccine companies. He is a Fellow of the UK Academy of Medical Sciences and the Royal College of Physicians.


Chair: Professor Freddie Hamdy

All members of the University and NHS clinical staff are welcome.


View the poster

Please email Louise King if you would like to attend.